arrow
Back
J

John Bridgewater

ucl cancer institute

65H-index
451Paper Count
3.5WCitation Count
Published Papers 143
Publication Date
Advanced Ampullary Cancer: post-hoc analysis of the ABC-01, -02 and -03 clinical trials
err2025-12-14
err0
errOAAI
errAngela Lamarca; Paul Ross; Harpreet S Wasan; Richard A Hubner; Mairéad G McNamara; Andre Lopes; Daniel Palmer; Juan W Valle; John Bridgewater
errShare
errSave
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
err2025-12-10
err0
errOAAI
errJesus M. Banales; Pedro M. Rodrigues; Silvia Affò; Jesper B. Andersen; Patricia Aspichueta; Luke Boulter; John Bridgewater; Diego F. Calvisi; Andres Cardenas; Vincenzo Cardinale; Guido Carpino; Cédric Coulouarn; Cristina Dopazo; Julien Edeline; Luca Fabris; Trine Folseraas; Alejandro Forner; Benjamin Goeppert; Mathias Heikenwalder; Timothy J. Kendall; Shahid A. Khan; Heinz-Josef Klümpen; Bas Groot Koerkamp; Angela Lamarca; Stacie Lindsey; Ana Lleo; Tom Luedde; Rocio I. R. Macias; Helen Morement; Jean-Charles Nault; Paula Olaizola; Maria J. Perugorria; Chiara Raggi; Lorenza Rimassa; Anna Saborowski; Juan W. Valle; Mathew Vithayathil; Arndt Vogel; Chiara Braconi
errShare
errSave
Gain of visceral adipose tissue rather than low skeletal muscle mass is associated with overall survival in patients with colorectal liver metastases; results from the NewEPOC study
err2025-11-19
err0
errOAAI
errMerel R. Aberle; Marjolein A.P. Ligthart; Malcolm A. West; Sander S. Rensen; Zina Eminton; David P.J. van Dijk; Sian A. Pugh; John A. Bridgewater; John N. Primrose; Steven W.M. Olde Damink
errShare
errSave
Epigenetically driven and early immune evasion in colorectal cancer evolution
err2025-11-05
err0
errOAAI
errEszter Lakatos; Vinaya Gunasri; Luis Zapata; Jacob Househam; Timon Heide; Nicholas Trahearn; Ottilie Swinyard; Luis Cisneros; Claire Lynn; Maximilian Mossner; Chris Kimberley; Inmaculada Spiteri; George D. Cresswell; Gerard Llibre-Palomar; Miriam Mitchison; Carlo C. Maley; Marnix Jansen; Manuel Rodriguez-Justo; John Bridgewater; Ann-Marie Baker; Andrea Sottoriva; Trevor A. Graham
errShare
errSave
Opportunities and Approaches to Optimising Advanced Cholangiocarcinoma Outcomes in the Era of Targeted Therapies: A Narrative Review
err2025-10-08
err0
errOAAI
errTeresa Macarulla; Cindy Neuzillet; Gerald W. Prager; Lorenza Rimassa; John Bridgewater
errShare
errSave
The colorectal liver metastasis growth pattern phenotype is not dependent on genotype
err2025-07-23
err0
errOAAI
errDiederik J. Höppener; Sanne M. L. Verheul; Pieter M. H. Nierop; Florian E. Buisman; Boris Galjart; Saskia M. Wilting; Siân A. Pugh; Susan D. Richman; Vinod P. Balachandran; William R. Jarnagin; T. Peter Kingham; Peter B. Vermeulen; Jinru Shia; Philip Quirke; John A. Bridgewater; Timothy S. Maughan; Bas Groot Koerkamp; Dirk J. Grünhagen; Cornelis Verhoef; John N. Primrose; Michael I. D’Angelica
errShare
errSave
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer
err2025-06-03
err0
PREAI
errFlorian Castet; Carles Fabregat-Franco; John Bridgewater; Jin Won Kim; Margherita Rimini; Adelaida La Casta; Angela Lamarca; Minsu Kang; Francesca Salani; Alfredo Castillo; Andre Lopes; Jaewon Hyung; Lorenza Rimassa; Jorge Adeva; Daniel López-Valbuena; Míriam Basagaña-Farres; Simran Vaja; Ka Man Mak; Tian V. Tian; Andrés Muñoz; Andrea Casadei-Gardini; Changhoon Yoo; Juan W. Valle; Teresa Macarulla
errShare
errSave
Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10dPrecision Medicine)
err2025-05-01
err0
PREAI
errMalka, D.; Borbath, I.; Lopes, A.; Couch, D.; Jimenez, M.; Vandamme, T.; Valle, J. W.; Wason, J.; Ambrose, E.; Dewever, L.; De Bruyne, I.; Edeline, J.; Bridgewater, J.
errShare
errSave
Plain language summary: an analysis of the safety of futibatinib treatment in people with different types of cancer
err2024-10-28
err0
errOAAI
errMeric-Bernstam, Funda; Hollebecque, Antoine; Furuse, Junji; Oh, Do-Youn; Bridgewater, John A.; Anderson, Bailey; Hangai, Nanae; Wacheck, Volker; Goyal, Lipika
errShare
errSave
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial
err2024-09-01
err0
PREAI
errMukherjee, Somnath; Qi, Cathy; Shaw, Rachel; Jones, Christopher M.; Bridgewater, John A.; Radhakrishna, Ganesh; Patel, Neel; Holmes, Jane; Virdee, Pradeep S.; Tranter, Bethan; Parsons, Philip; Falk, Stephen; Wasan, Harpreet S.; Ajithkumar, Thankamma, V; Holyoake, Daniel; Roy, Rajarshi; Scott-Brown, Martin; Hurt, Christopher N.; O'Neill, Eric; Sebag-Montefiore, David; Maughan, Tim S.; Hawkins, Maria A.; Corrie, Pippa
errShare
errSave
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
err2024-08-08
err1
errOAAI
errHarding, James J.; Fan, Jia; Oh, Do-Youn; Choi, Hye Jin; Kim, Jin Won; Chang, Heung-Moon; Bao, Lequn; Sun, Hui-Chuan; Macarulla, Teresa; Xie, Feng; Metges, Jean-Phillippe; Ying, Jie'er; Bridgewater, John; Lee, Myung-Ah; Tejani, Mohamedtaki A.; Chen, Emerson Y.; Kim, Dong Uk; Wasan, Harpreet; Ducreux, Michel; Bao, Yuanyuan; Lindsey, Stacie; Bachini, Melinda; Morement, Helen; Boyken, Lisa; Ma, Jiafang; Garfin, Phillip; Pant, Shubham
errShare
errSave
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy Post Hoc Analysis of the SCOT Randomized Clinical Trial
err2024-08-01
err1
PREAI
errGogenur, Mikail; Rosen, Andreas Weinberger; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; Pearson, Sarah; Boyd, Kathleen A.; Briggs, Andrew H.; Waterston, Ashita; Medley, Louise; Ellis, Richard; Dhadda, Amandeep S.; Harrison, Mark; Falk, Stephen; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Cunningham, David; Hickish, Tamas; Gollins, Simon; Wasan, Harpreet S.; Kelly, Caroline; Goegenur, Ismail; Hollaender, Niels Henrik
errShare
errSave
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer
err2024-06-17
err0
errOAAI
errGoyal, Lipika; Meric-Bernstam, Funda; Hollebecque, Antoine; Valle, Juan W.; Morizane, Chigusa; Karasic, Thomas B.; Abrams, Thomas A.; Furuse, Junji; Kelley, Robin Katie; Cassier, Philippe A.; Klumpen, Heinz-Josef; Chang, Heung-Moon; Chen, Li-Tzong; Tabernero, Josep; Oh, Do-Youn; Mahipal, Amit; Moehler, Markus; Komatsu, Yoshito; Ahn, Daniel H.; Epstein, Robert S.; Halim, Abdel-Baset; Wacheck, Volker; He, Yaohua; Liu, Mei; Benhadji, Karim A.; Bridgewater, John A.
errShare
errSave
Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial
err2024-06-14
err0
errOAAI
errOh, Do-Youn; Ikeda, Masafumi; Lee, Choong-kun; Rojas, Carlos; Hsu, Chih-Hung; Kim, Jin Won; Shen, Lin; Furuse, Junji; Park, Joon Oh; Borad, Mitesh; de Braud, Filippo; Bridgewater, John; Lee, Sunyoung S.; Moehler, Markus; Audhuy, Francois; Osada, Motonobu; Sato, Masashi; Yoo, Changhoon
errShare
errSave
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients
err2024-02-08
err5
errOAAI
errMeric-Bernstam, Funda; Hollebecque, Antoine; Furuse, Junji; Oh, Do-Youn; Bridgewater, John A.; Shimura, Masashi; Anderson, Bailey; Hangai, Nanae; Wacheck, Volker; Goyal, Lipika
errShare
errSave
Clinical activity of lirafugratinib (RLY-4008), a highly selective FGFR2 inhibitor, in patients with advanced FGFR2-altered solid tumors: The ReFocus study
err2023-12-01
err0
PREAI
errSchram, Alison M.; Subbiah, Vivek; Liao, Chih-Yi (Andy); Moreno, Victor; Desamparados, Roda; Ponz-Sarvise, Mariano; Dotan, Efrat; Cassier, Philippe Alexandre; Moreno, Irene; Varkaris, Andreas; Kim, Richard D.; Garralda, Elena; Opdam, Frans; Tai, David; Italiano, Antoine; Oh, Do-Youn; Goyal, Lipika; Fontana, Elise; Liu, Jia; Boukovala, Myrto; Ghiringelli, Francois; Borad, Mitesh J.; Babiker, Hani; Jin, Zhaohui; Millward, Michael; Yachnin, Jeffrey; Kamath, Suneel Deepak; Coward, Jermaine M.; Yoo, Changhoon; Kelley, Robin Kate; Sahai, Vaibhav; Bridgewater, John; Springfield, Christoph; Florou, Vaia; El-Khoueiry, Anthony; Eskens, Ferry; Lin, Bruce; Paulson, Scott; Curigliano, Giuseppe; Murphy, Meredith; Deary, Alicia; Ricard, Fabien; Jen, Kai Yu; Ramirez, Florence (Tianhui); Blakesley, Rick E.; Schmidt-Kittler, Oleg; Mar, Brenton G.; Park, Joon Oh; Hollebecque, Antoine
errShare
errSave
Quality of life (QoL) outcomes in patients (pts) with zanidatamab (zani)-treated HER2-positive (HER2+) biliary tract cancer (BTC) in the phase IIb HERIZON-BTC-01 study
err2023-10-01
err0
errOAAI
errWasan, H. S.; Harding, J. J.; Fan, J.; Oh, D-Y.; Choi, H. J.; Kim, J. W.; Chang, H-M.; Bao, L.; Sun, H.; Macarulla, T.; Xie, F.; Metges, J-P.; Ying, J.; Bridgewater, J. A.; Tejani, M.; Chen, E. Y.; Ducreux, M. P.; Ma, J.; Garfin, P.; Pant, S.
errShare
errSave
errShare
errSave